Last Updated On 3/29/2024 6:52:47 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| No Relationships to Disclose |
|
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Exelixis |
| Recipient: Your Institution |
| Company: Merck |
| Recipient: Your Institution |
| Company: QED Therapeutics |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| Company: Clovis Oncology, Inc. |
| Recipient: You |
| Company: AstraZeneca Pharmaceuticals LP |
| Recipient: You |
| Company: PROCEPT BioRobotics Corporation |
| Recipient: You |
| Company: Dendreon |
| Recipient: You |
| Company: Seagen |
| Recipient: You |
| Company: Progenics |
| Recipient: You |
| Company: AstraZeneca |
| Recipient: You |
| Company: Foundation Medicine |
| Recipient: You |
| Company: Janssen Scientific Affairs |
| Recipient: You |
| Company: Myovant Sciences |
| Recipient: You |
| Company: Gilead Sciences |
| Recipient: You |
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| No Relationships to Disclose |
|
|